arrow
Back
T

Toshio Imai

KAN Research Institute

67H-index
400Paper Count
1.9WCitation Count
Published Papers 129
Publication Date
Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium (vol 4, pg 1881, 2024)
err2025-11-01
err0
errOAAI
errEng, Jason W. -L.; Kato, Yu; Adachi, Yusuke; Swaminathan, Bhairavi; Naiche, L. A.; Vadakath, Rahul; Sakamoto, Yoshimasa; Nakazawa, Youya; Tachino, Sho; Ito, Ken; Abe, Takanori; Minoshima, Yukinori; Hoshino-Negishi, Kana; Ogasawara, Hideaki; Kawakatsu, Tomomi; Nishimura, Miyuki; Katayama, Masahiko; Shimizu, Masashi; Tahara, Kazuhiro; Sato, Toshitaka; Suzuki, Katsuhisa; Agarwala, Kishan; Iwata, Masao; Nomoto, Kenichi; Ozawa, Yoichi; Imai, Toshio; Funahashi, Yasuhiro; Matsui, Junji; Kitajewski, Jan
errShare
errSave
Histological characteristics of primary biliary cholangitis in patients with incomplete responses to ursodeoxycholic acid
err2025-10-22
err0
errOAAI
errKenichi Harada; Yuko Kakuda; Atsushi Tanaka; Masanori Abe; Tadashi Namisaki; Shinji Shimoda; Mikio Zeniya; Akio Ido; Hitoshi Yoshiji; Hiromasa Ohira; Atsushi Umeda; Yuki Kamiya; Yukari Higashine; Seiichiro Hojo; Toshio Imai; Tetsu Kawano; Hirohito Tsubouchi; Yasuni Nakanuma
errShare
errSave
Comparative Aptamer Profiling Reveals Cell Surface Remodeling and Emergence of Noncanonical Cell Surface Protein Under Oncogenic Signaling
err2025-10-04
err0
errOAAI
errJungo Kakuta; Kenji Ohba; Hideaki Ogasawara; Kyohei Okahara; Kazumi Emoto; Hiroaki Sako; Miho Sekai; Yasuyuki Fujita; Toshio Imai; Yogo Sakakibara
errShare
errSave
A placebo-controlled Phase 2 trial of E6011, anti-human fractalkine monoclonal antibody, in primary biliary cholangitis
err2025-06-01
err0
errOAAI
errAtsushi Tanaka; Masanori Abe; Tadashi Namisaki; Shinji Shimoda; Mikio Zeniya; Akio Ido; Hitoshi Yoshiji; Hiromasa Ohira; Kenichi Harada; Yuko Kakuda; Atsushi Umeda; Yuki Kamiya; Yukari Higashine; Seiichiro Hojo; Toshio Imai; Tetsu Kawano; Yasuni Nakanuma; Hirohito Tsubouchi
errShare
errSave
Clinical outcome of treatment rechallenge with HER2directed antibody-drug conjugate in metastatic breast cancer
err2024-10-01
err0
PREAI
errAndo, M. M.; Shimoi, T.; Imai, T.; Kojima, Y.; Sudo, K.; Yonemori, K.
errShare
errSave
Impact of intratumoral microbiome on tumor immunity and prognosis in human pancreatic ductal adenocarcinoma
err2024-01-20
err10
errOAAI
errAbe, Shohei; Masuda, Atsuhiro; Matsumoto, Tomonori; Inoue, Jun; Toyama, Hirochika; Sakai, Arata; Kobayashi, Takashi; Tanaka, Takeshi; Tsujimae, Masahiro; Yamakawa, Kohei; Gonda, Masanori; Masuda, Shigeto; Uemura, Hisahiro; Kohashi, Shinya; Inomata, Noriko; Nagao, Kae; Harada, Yoshiyuki; Miki, Mika; Irie, Yosuke; Juri, Noriko; Ko, Testuhisa; Yokotani, Yusuke; Oka, Yuki; Ota, Shogo; Kanzawa, Maki; Itoh, Tomoo; Imai, Toshio; Fukumoto, Takumi; Hara, Eiji; Kodama, Yuzo
errShare
errSave
A comprehensive analysis of tumor-stromal collagen in relation to pathological, molecular, and immune characteristics and patient survival in pancreatic ductal adenocarcinoma
err2023-07-21
err5
errOAAI
errAshina, Shigeto; Masuda, Atsuhiro; Yamakawa, Kohei; Hamada, Tsuyoshi; Tsujimae, Masahiro; Tanaka, Takeshi; Toyama, Hirochika; Sofue, Keitaro; Shiomi, Hideyuki; Sakai, Arata; Kobayashi, Takashi; Abe, Shohei; Gonda, Masanori; Masuda, Shigeto; Inomata, Noriko; Uemura, Hisahiro; Kohashi, Shinya; Nagao, Kae; Harada, Yoshiyuki; Miki, Mika; Juri, Noriko; Irie, Yosuke; Kanzawa, Maki; Itoh, Tomoo; Inoue, Jun; Imai, Toshio; Fukumoto, Takumi; Kodama, Yuzo
errShare
errSave
ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
err2022-10-22
err3
errOAAI
errTsukamoto, Shuntaro; Sugi, Naoko Hata; Nishibata, Kyoko; Nakazawa, Youya; Ito, Daisuke; Fukushima, Sayo; Nakagawa, Takayuki; Ichikawa, Kenji; Kato, Yu; Kakiuchi, Dai; Goto, Aya; Itoh-Yagi, Machiko; Aota, Tomoki; Inoue, Satoshi; Yamane, Yoshinobu; Murai, Norio; Azuma, Hiroshi; Nagao, Satoshi; Sasai, Ken; Akag, Tsuyosh; Imai, Toshio; Matsui, Junji; Matsushima, Tomohiro
errShare
errSave
The Fractalkine-CX3CR1 Axis Regulates Non-inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival
err2022-09-22
err4
errOAAI
errKuboi, Yoshikazu; Kuroda, Yukiko; Ohkuro, Masayoshi; Motoi, Sotaro; Tomimori, Yoshiya; Yasuda, Hisataka; Yasuda, Nobuyuki; Imai, Toshio; Matsuo, Koichi
errShare
errSave
Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma
err2022-02-01
err16
PREAI
errMiyamoto, Shingo; Nagano, Yoshiko; Miyazaki, Makoto; Nagamura, Yuko; Sasaki, Kazuki; Kawamura, Takeshi; Yanagihara, Kazuyoshi; Imai, Toshio; Ohki, Rieko; Yashiro, Masakazu; Tanaka, Masato; Sakai, Ryuichi; Yamaguchi, Hideki
errShare
errSave
Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs (vol 11, 2077, 2021)
err2021-07-29
err1
errOAAI
errNaruse, Mie; Ochiai, Masako; Sekine, Shigeki; Taniguchi, Hirokazu; Yoshida, Teruhiko; Ichikawa, Hitoshi; Sakamoto, Hiromi; Kubo, Takashi; Matsumoto, Kenji; Ochiai, Atsushi; Imai, Toshio
errShare
errSave
Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice
err2021-05-17
err11
errOAAI
errMizutani, Satoshi; Nishio, Junko; Kondo, Kanoh; Motomura, Kaori; Yamada, Zento; Masuoka, Shotaro; Yamada, Soichi; Muraoka, Sei; Ishii, Naoto; Kuboi, Yoshikazu; Sendo, Sho; Mikami, Tetuo; Imai, Toshio; Nanki, Toshihiro
errShare
errSave
Phase 1 study on the safety and efficacy of E6011, antifractalkine antibody, in patients with Crohn's disease
err2021-03-31
err13
errOAAI
errMatsuoka, Katsuyoshi; Naganuma, Makoto; Hibi, Toshifumi; Tsubouchi, Hirohito; Oketani, Kiyoshi; Katsurabara, Toshinori; Hojo, Seiichiro; Takenaka, Osamu; Kawano, Tetsu; Imai, Toshio; Kanai, Takanori
errShare
errSave
Efficacy and Safety of E6011, an Anti-Fractalkine Monoclonal Antibody, in Patients With Active Rheumatoid Arthritis With Inadequate Response to Methotrexate: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study
err2021-02-18
err16
errOAAI
errTanaka, Yoshiya; Takeuchi, Tsutomu; Yamanaka, Hisashi; Nanki, Toshihiro; Umehara, Hisanori; Yasuda, Nobuyuki; Tago, Fumitoshi; Kitahara, Yasumi; Kawakubo, Makoto; Torii, Kentaro; Hojo, Seiichiro; Kawano, Tetsu; Imai, Toshio
errShare
errSave
Emerging Role of Fractalkine in the Treatment of Rheumatic Diseases
err2020-11-01
err27
errOAAI
errTanaka, Yoshiya; Hoshino-Negishi, Kana; Kuboi, Yoshikazu; Tago, Fumitoshi; Yasuda, Nobuyuki; Imai, Toshio
errShare
errSave
Rationale for and clinical development of anti-fractalkine antibody in rheumatic diseases
err2020-05-13
err8
PREAI
errMuraoka, Sei; Nishio, Junko; Kuboi, Yoshikazu; Imai, Toshio; Nanki, Toshihiro
errShare
errSave
An organoid-based carcinogenesis model induced by in vitro chemical treatment
err2020-02-12
err21
PREAI
errNaruse, Mie; Masui, Ryoichi; Ochiai, Masako; Maru, Yoshiaki; Hippo, Yoshitaka; Imai, Toshio
errShare
errSave
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways (vol 12, pg 289, 2019)
err2019-11-15
err0
errOAAI
errMoro, Hiroshi; Hattori, Naoko; Nakamura, Yoshiaki; Kimura, Kana; Imai, Toshio; Maeda, Masahiro; Yashiro, Masakazu; Ushijima, Toshikazu
errShare
errSave
Epigenetic priming sensitizes gastric cancer cells to irinotecan and cisplatin by restoring multiple pathways
err2019-09-25
err26
errOAAI
errMoro, Hiroshi; Hattori, Naoko; Nakamura, Yoshiaki; Kimura, Kana; Imai, Toshio; Maeda, Masahiro; Yashiro, Masakazu; Ushijima, Toshikazu
errShare
errSave